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To the editor,
   Several emerging of the new bird flu infections within the 
past few years lead a great concern to the medical society. 
The greatest consideration at present is on H7N9 bird flu[1]. 
There are also other human bird flu to be concerned including 
H1N1 and H7N7 bird flu. However, there is an interesting bird 
flu, H5N2, that should be discussed for its infection in human 
beings. H5N2 influenza virus is a well-known virus that can 
cause infection in avian. This virus can cause outbreak in 
avian and can also be isolated from asymptomatic avian[2]. 
The human H5N2 bird flu is a controversial issue. Whether the 
H5N2 bird flu virus can cause the disease in human being or 
not requires further extensive study. The first report on the 
observation of H5N2 bird flu in human beings is from Japan. 
In 2005, a large H5N2 avian influenza outbreak among chicken 
occurred in Ibaraki, Japan[3]. After this outbreak, there are 
some reports on the possibility of human H5N2 influenza virus 
infection. The seropositivity of the workers working in the 
farms that H5N2 outbreak in avian was reported[4]. Yamazaki 
et al. performed a serological survey of avian H5N2-subtype 
influenza virus infections among poultry workers and found 
that seropositivity was significantly associated with age[4]. 
A similar observation was also reported by Ogata et al[5]. 
Nevertheless, there was no influenza symptom among the 
seropositive case[4,5]. Yamazaki et al. noted that this might 
be the first evidence of human infection[4]. However, Ogata 
et al. raised an important concern that “a history of seasonal 
influenza vaccination might be associated with H5N2-
neutralizing antibody positivity”[5]. Also, Yamazaki et al. 
found that administration of oseltamivir might also affect 
the result of immunological test[6]. After that, there are some 
reports on the seropositivity in human beings and possible 
relations to some clinical features such as conjunctivitis[7,8]. 
The most recent report was from Nigeria in 2013[7]. Okoye et al. 
reported the seropositivity among both animal-exposed and 
non animal-exposed subjects and proposed for “occasional 
virus transmission to humans”[7]. However, there are still no 
confirmation when a systemic epidemiology investigation is 
applied[8]. Nevertheless, the cross species infection from avian 
to mammal of H5N2 virus has already been confirmed in pigs 
and the possibility for further genetic reassortment to cause 
new H5N2 virus that might be highly virulent to human beings 
is also proposed[9]. It is no doubt that the special concern and 
appropriate surveillance on the possible emerging human 
H5N2 bird flu is needed.
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